Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-licensure Observational Safety Surveillance Study of Quadrivalent Meningococcal ACWY Conjugate Vaccine MenACWY-CRM (Menveo) Vaccination in Children 2 Through 10 Years of Age

NCT01452438 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.

NCT NCT01452438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01452438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-licensure Observational Safety Surveillance Study of Quadrivalent Meningococcal ACWY Conjugate Vaccine MenACWY-CRM (Menveo) Vaccination in Children 2 Through 10 Years of Age
Lead sponsor
Novartis Vaccines
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
July 31, 2015
Enrollment
393 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal disease